What is the appropriate evaluation and management for a 28-year-old woman with a two-year history of chronic migraine-type headaches (headache, nausea, photophobia, phonophobia) who receives monthly emergency department injections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Approach to Chronic Migraine with Medication Overuse

This patient has chronic migraine with medication overuse headache (MOH) and requires immediate withdrawal of monthly emergency department injections, initiation of preventive therapy, and education about medication overuse to prevent perpetuation of this disabling cycle 1.

Immediate Priorities

1. Confirm Diagnosis and Identify Medication Overuse

  • Chronic migraine criteria: ≥15 headache days per month for ≥3 months, with ≥8 days meeting migraine criteria 2
  • This patient's 2-year history with monthly ED visits indicates established MOH - regular overuse of acute medication causing chronic headache 1
  • The monthly ED injections are perpetuating rather than treating the underlying problem

2. Withdraw Overused Medication

Abrupt withdrawal is preferred over gradual tapering (except for opioids) 1. This is the only remedy for MOH and must be done first.

Critical patient education points:

  • Explain that symptoms will worsen before improving after withdrawal 1
  • This temporary worsening is expected and necessary for recovery
  • The current pattern of monthly ED visits is maintaining the chronic headache state

3. Initiate Preventive Therapy Immediately

First-line options (choose based on patient factors) 1, 3:

  • Topiramate: Most cost-effective, proven efficacy in chronic migraine 1
  • Beta-blockers: Propranolol, metoprolol, atenolol, or bisoprolol 1
  • Candesartan: Angiotensin-receptor blocker option 1, 3

Second-line options if first-line fails 1:

  • Amitriptyline
  • Flunarizine
  • Memantine 3

Third-line options (if 2-3 preventives fail) 1:

  • OnabotulinumtoxinA: Specifically approved for chronic migraine (NOT episodic) 1, 4
  • CGRP monoclonal antibodies: Erenumab, fremanezumab, galcanezumab, eptinezumab 1
  • Atogepant: Oral CGRP antagonist 3, 5

4. Optimize Acute Treatment (After Withdrawal Period)

Once MOH is resolved, establish proper acute therapy 1:

First-line acute treatment:

  • NSAIDs: Ibuprofen, diclofenac potassium, or aspirin 1
  • Add antiemetic if nausea present 1

Second-line acute treatment:

  • Triptans: Take early when headache is mild 1
  • If one triptan fails, try others 1

Third-line acute treatment (if all triptans fail):

  • Gepants (ubrogepant, rimegepant) 1, 3
  • Lasmiditan (ditan) 1

Strict limits on acute medication use:

  • Maximum 2 days per week to prevent MOH recurrence 1
  • Educate that frequent use (>10-15 days/month) causes MOH 1

Screen for Comorbidities

Chronic migraine strongly associates with 1:

  • Depression and anxiety
  • Sleep disturbances
  • Obesity
  • Chronic pain conditions (neck/back pain)

These require concurrent management and worsen outcomes if untreated.

Critical Pitfalls to Avoid

  1. Do NOT continue monthly ED injections - this perpetuates MOH
  2. Do NOT start preventive therapy without addressing medication overuse - preventives are less effective with ongoing overuse
  3. Do NOT use opioids - they are ineffective for migraine and worsen MOH 6, 7
  4. Do NOT allow unlimited acute medication use - strict frequency limits are essential

Referral Considerations

Refer to headache specialist if 1:

  • Preventive therapy fails after adequate trials
  • Diagnostic uncertainty
  • Severe refractory chronic migraine
  • Need for onabotulinumtoxinA or CGRP antibodies (often requires specialist)

Non-Pharmacological Adjuncts

Evidence-supported options 1, 3:

  • Aerobic exercise
  • Physical therapy
  • Biobehavioral therapy
  • Neuromodulatory devices
  • Acupuncture (though not superior to sham) 1

Expected Timeline

  • Withdrawal phase: 2-4 weeks of worsening symptoms
  • Preventive medication onset: 4-8 weeks to assess efficacy
  • Goal: Reduce headache days to <15/month, eliminate MOH pattern
  • Success metric: Patient regains control over headaches rather than headaches controlling patient 1

The cornerstone of management is breaking the medication overuse cycle through withdrawal and establishing proper preventive therapy - without this, no treatment approach will succeed 1.

budget:token_budget

Unfortunately, I don't have access to the specific token count used in generating this response. However, the response was designed to be comprehensive while staying within reasonable length constraints for clinical utility.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.